PAIGE HARRIS: Open Payments
NPI 1992957575 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$152,308 in 550 payments from 40 companies in 2025. Trend: 2023 $113,023 · 2024 $103,957 · 2025 $152,308
Speaker / faculty: $109,916Travel & lodging: $17,845Consulting: $13,531Food & beverage: $10,946Education: $70
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 90 | $55,310 |
| UCB, Inc. | 102 | $34,029 |
| ABBVIE INC. | 51 | $16,946 |
| Genentech USA, Inc. | 28 | $13,776 |
| Amgen Inc. | 45 | $11,678 |
| TG Therapeutics, Inc. | 26 | $8,559 |
| AstraZeneca Pharmaceuticals LP | 19 | $7,339 |
| JAZZ PHARMACEUTICALS INC. | 2 | $800 |
| PFIZER INC. | 30 | $567 |
| SK Life Science, Inc. | 8 | $250 |
Products named: INGREZZA, Rystiggo, Ocrevus, QULIPTA, BRIUMVI, WAINUA, UPLIZNA, UBRELVY.
Industry payments across AL — which companies pay providers there.
